BR112017016437A2 - ?vacina, uso de um antígeno de lawsonia intracellularis não vivo, e, método para reduzir em um porco a liberação das bactérias lawsonia intracellularis associada com infecção subclínica com lawsonia intracellularis? - Google Patents

?vacina, uso de um antígeno de lawsonia intracellularis não vivo, e, método para reduzir em um porco a liberação das bactérias lawsonia intracellularis associada com infecção subclínica com lawsonia intracellularis?

Info

Publication number
BR112017016437A2
BR112017016437A2 BR112017016437A BR112017016437A BR112017016437A2 BR 112017016437 A2 BR112017016437 A2 BR 112017016437A2 BR 112017016437 A BR112017016437 A BR 112017016437A BR 112017016437 A BR112017016437 A BR 112017016437A BR 112017016437 A2 BR112017016437 A2 BR 112017016437A2
Authority
BR
Brazil
Prior art keywords
lawsonia intracellularis
vaccine
pig
nonliving
reducing
Prior art date
Application number
BR112017016437A
Other languages
English (en)
Inventor
Arnoldus Christiaan Jacobs Antonius
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52440619&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112017016437(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BR112017016437A2 publication Critical patent/BR112017016437A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

a presente invenção se refere a uma vacina compreendendo antígeno de lawsonia intracellularis não vivo e um carreador farmaceuticamente aceitável para uso em um método para reduzir em um porco o impacto negativo no ganho de peso diário médio (adwg) associado com infecção subclínica com lawsonia intracellularis, por administração sistêmica da vacina ao porco.
BR112017016437A 2015-02-04 2016-02-03 ?vacina, uso de um antígeno de lawsonia intracellularis não vivo, e, método para reduzir em um porco a liberação das bactérias lawsonia intracellularis associada com infecção subclínica com lawsonia intracellularis? BR112017016437A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15153782 2015-02-04
PCT/EP2016/052239 WO2016124623A1 (en) 2015-02-04 2016-02-03 A vaccine for use against subclinical lawsonia infection in a pig

Publications (1)

Publication Number Publication Date
BR112017016437A2 true BR112017016437A2 (pt) 2018-04-10

Family

ID=52440619

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017016437A BR112017016437A2 (pt) 2015-02-04 2016-02-03 ?vacina, uso de um antígeno de lawsonia intracellularis não vivo, e, método para reduzir em um porco a liberação das bactérias lawsonia intracellularis associada com infecção subclínica com lawsonia intracellularis?

Country Status (8)

Country Link
US (1) US10265392B2 (pt)
EP (1) EP3253410B1 (pt)
JP (2) JP2018504423A (pt)
CN (1) CN107249625B (pt)
BR (1) BR112017016437A2 (pt)
ES (1) ES2798282T3 (pt)
RU (1) RU2709197C2 (pt)
WO (1) WO2016124623A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016124620A1 (en) 2015-02-04 2016-08-11 Intervet International B.V. A vaccine for use against subclinical lawsonia infection in a pig

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885823A (en) * 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
JP2000502054A (ja) * 1995-11-30 2000-02-22 アグリカルチャー ビクトリア サービシーズ ピーティーワイ．エルティーディー． 治療用および診断用の組成物
US7029683B1 (en) * 1999-05-13 2006-04-18 Pfizer Products, Inc. Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
JP2004529854A (ja) 2000-09-29 2004-09-30 アリゾナ・ボード・オブ・リージエンツ・オン・ビハーフ・オブ・ザ・ユニバーシテイー・オブ・アリゾナ 増殖性回腸炎のための改善されたワクチン及びその作製と使用の方法
DK1219711T3 (da) 2000-12-20 2006-09-25 Intervet Int Bv Lawsonia Intracellularis vaccine
JP2006528882A (ja) 2003-07-25 2006-12-28 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド 欧州起源のローソニア・イントラセルラリス並びにそのワクチン、診断薬及び使用方法
KR20060134054A (ko) 2004-01-22 2006-12-27 인터벳 인터내셔널 비.브이. 로소니아 인트라셀룰라리스 서브유닛 백신
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
EP2101815A4 (en) * 2006-12-11 2010-10-06 Boehringer Ingelheim Vetmed EFFICIENT PROCESS FOR THE TREATMENT OF PORCINE CIRCOVIRUS AND LAWSONIA INTRACELLULARIS INFECTIONS
EP2200643B1 (en) * 2007-09-17 2013-09-04 Boehringer Ingelheim Vetmedica, Inc. A live lawsonia intracellularis vaccine administered in combination with an antibiotic for use in the treatment of lawsonia intracellularis infections in pigs
TWI449533B (zh) * 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
TWI551295B (zh) * 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
US8142760B2 (en) * 2008-09-05 2012-03-27 Nathan Len Winkelman Vaccination for Lawsonia intracellularis
ES2695172T3 (es) * 2013-12-03 2019-01-02 Intervet Int Bv Vacuna porcina contra SRRP y Lawsonia intracellularis
EP3076995B1 (en) * 2013-12-03 2020-03-11 Intervet International B.V. Vaccine against lawsonia intracellularis and porcine circovirus 2
WO2016124620A1 (en) 2015-02-04 2016-08-11 Intervet International B.V. A vaccine for use against subclinical lawsonia infection in a pig

Also Published As

Publication number Publication date
ES2798282T3 (es) 2020-12-10
RU2017130459A (ru) 2019-03-04
JP2021035982A (ja) 2021-03-04
US10265392B2 (en) 2019-04-23
CN107249625B (zh) 2021-09-03
CN107249625A (zh) 2017-10-13
EP3253410A1 (en) 2017-12-13
JP2018504423A (ja) 2018-02-15
WO2016124623A1 (en) 2016-08-11
RU2017130459A3 (pt) 2019-07-30
US20180000924A1 (en) 2018-01-04
EP3253410B1 (en) 2020-05-06
RU2709197C2 (ru) 2019-12-17

Similar Documents

Publication Publication Date Title
CL2016001235A1 (es) Cepa bacteriana aislada del genero burkholderia y metabolitos plaguicidas derivados-formulaciones y usos (divisional solicitud 467-2014).
EP3616716A3 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
AR101455A1 (es) Molécula portadora
BR112015004515A2 (pt) composição imunogênica
CL2016000008A1 (es) Tratamiento de lesiones inflamatorias de rosacea con ivermectina.
CO2020000328A2 (es) Formulaciones a largo plazo
PH12015501716B1 (en) Anti-mycoplasma spp. subunit vaccine
CL2015001562A1 (es) Método para obtener una vacuna de mycoplasma.
BR112015011828A2 (pt) sistema de guia de uma porta de correr
PH12016500946A1 (en) Composition for preventing and curing mycoplasma infection
PH12019500330A1 (en) Porcine epidemic diarrhea preventative or therapeutic method, vaccine, and vaccine kit
PH12019502316A1 (en) Combination cancer immunotheraphy with pentaaza macrocyclic ring complex
PH12017501806A1 (en) Anthelmintic combinations and methods of use thereof
BR112017022755A2 (pt) formulações de glucopiranosil lipídeo a e alérgeno a amendoim para administração sublingual
EP4241851A3 (en) Immunogenic compositions
BR112018014723A2 (pt) fantasmas bacterianos para o tratamento de câncer
BR112017016429A2 (pt) ?vacina, uso de um antígeno de lawsonia intracellularis não vivo, e, método para reduzir o impacto negativo no ganho de peso diário médio (adwg) de um porco associado com infecção subclínica com lawsonia intracellularis?
CR20160495A (es) Composiciones libres de células para la restauración de células y métodos para la preparación y utilización de las mismas
BR112015030697A2 (pt) Vacina semiviva contra o vírus sincicial respiratório
BR112016012393A8 (pt) vacina, e, uso de uma combinação de um vírus prrs atenuado vivo e um antígeno de lawsonia intracellularis inativado
BR112017016437A2 (pt) ?vacina, uso de um antígeno de lawsonia intracellularis não vivo, e, método para reduzir em um porco a liberação das bactérias lawsonia intracellularis associada com infecção subclínica com lawsonia intracellularis?
BR112016012435A2 (pt) Vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2
CL2018001680A1 (es) Composiciones y métodos de uso de nuevas cepas de lactobacillus fermentum
BR112017012938A2 (pt) uso por via oral de uma composição e método para aprimorar a aparência da celulite
BR112015032468A2 (pt) vacina para disenteria suína

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 7.1 NA RPI NO 2779 DE 09/04/2024 POR TER SIDO INDEVIDA.